Your browser doesn't support javascript.
loading
Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction.
Weiss, Thomas W; Aichinger, Josef; Huber, Kurt; Speidl, Walter S; Watzinger, Norbert; Zweiker, Robert; Alber, Hannes F.
Afiliação
  • Weiss TW; 3rd Medical Department of Cardiology and Intensive Care Medicine, Wilhelminenhospital, Vienna, Austria. thomas.weiss@meduniwien.ac.at.
  • Aichinger J; Internal Department 2 - Cardiology, Angiology and Internal Intensive Medicine, Krankenhaus der Elisabethinen Linz, Linz, Austria.
  • Huber K; 3rd Medical Department of Cardiology and Intensive Care Medicine, Wilhelminenhospital, Vienna, Austria.
  • Speidl WS; Clinical Department of Cardiology, University Clinic of General Medicine II, Medical University of Vienna, Vienna, Austria.
  • Watzinger N; Department of General Medicine, Landeskrankenhaus Feldbach, Feldbach-Fürstenfeld Hospital Group, Feldbach, Austria.
  • Zweiker R; Department of Cardiology, Medical University of Graz, Graz, Austria.
  • Alber HF; University Clinic of General Medicine III at the Medical University of Innsbruck, Reha-Zentrum Münster, Tyrol and Karl Landsteiner Institute for Interdisciplinary Research at the Reha-Zentrum Münster, Münster/Tyrol, Austria.
Wien Klin Wochenschr ; 128(11-12): 450-7, 2016 Jun.
Article em En | MEDLINE | ID: mdl-27278134
ABSTRACT
The protective effect of dual antiplatelet therapy (DAPT) following acute coronary syndrome is undisputed, but its duration is subject of debate. Several studies show that prolonged therapy provides a clinical benefit in patients following acute coronary syndrome. The aim of this position paper authored by Austrian experts is to outline the current evidence and provide an overview of recent studies. It is also intended to serve as a practical guide to identify those patients who may benefit from prolonged DAPT.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Aspirina / Guias de Prática Clínica como Assunto / Prevenção Secundária / Antagonistas do Receptor Purinérgico P2Y / Infarto do Miocárdio Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Aspirina / Guias de Prática Clínica como Assunto / Prevenção Secundária / Antagonistas do Receptor Purinérgico P2Y / Infarto do Miocárdio Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article